Conservative Management of Morbidly Adherent Anterior Situated Placenta
Primary Purpose
Placenta Accreta
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Cervico- isthmic compression suture
Anterior wall uterine resection:
Sponsored by
About this trial
This is an interventional treatment trial for Placenta Accreta
Eligibility Criteria
Inclusion Criteria:
1- Patient with FIGO classification of PAS disorders Grade 1 & Grade 2 which diagnosed by :
- Loss of normal hypoechoic retroplacental zone.
- Multiple vascular lacunae (irregular vascular spaces) within placenta, giving "Swiss cheese" appearance.
- Retroplacental myometrial thickness of less 1 mm. 2- Patient welling to preserve fertility.
Exclusion Criteria:
1- Patient with FIGO classification of PAS disorders Grade 3 (interruption of the hyperechoic border between the uterine serosa and bladder by US).
2- Age : >40 years old. 3- Patient has medical disorders: cardiac disease, uncontrolled DM, chronic renal disease, chronic liver disease.
4- Patient who refuse to participate in the study.
Sites / Locations
- Faculty of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Group A
Group B
Arm Description
Circular isthmic-cervical sutures
Resection of the infiltrated part of anterior uterine wall
Outcomes
Primary Outcome Measures
estimated blood loss
The amount of blood drawn into the storage jar during surgery (suction apparatus).
The weight of blood-soaked gauze pads, gauzes, and surgical dressings minus their preoperative weight, and corresponding conversion according to the proportion of 1.05 g in weight to 1 ml in volume.
Secondary Outcome Measures
hemoglobin deficit
Compare hemoglobin and hematocrit values before and after operation.
complication rate
Injury to local organs (e.g., bowel, bladder, uterus and neurovascular structures in the retroperitoneum and lateral pelvic sidewalls from placental implantation and its removal).
Postpartum hemorrhage, Internal hemorrhage.
Amniotic fluid embolism.
Massive blood transfusion: acidosis, hypothermia, coagulopathy, electrolyte abnormalities and infection.
Postoperative thromboembolism, infection, multisystem organ failure, and maternal death
Hysterectomy.
Full Information
NCT ID
NCT04579172
First Posted
October 1, 2020
Last Updated
April 5, 2022
Sponsor
Mansoura University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04579172
Brief Title
Conservative Management of Morbidly Adherent Anterior Situated Placenta
Official Title
Cervico-Isthmic Compression Suture Versus Anterior Wall Uterine Resection in Cases of Morbidly Adherent Anterior Situated Placenta
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
September 30, 2020 (Actual)
Primary Completion Date
October 1, 2021 (Actual)
Study Completion Date
November 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Placenta accreta is defined as abnormal trophoblast invasion of part or the entire placenta into the myometrium of the uterine wall. Placenta accreta spectrum (PAS), formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, percreta, and accreta.
An important risk factor of placenta accreta is placenta previa in the presence of a uterine scar. Placenta previa is an independent risk factor for placenta accreta.Additional reported risk factors for placenta accreta include increased maternal age and multiparity, other prior uterine surgery, prior uterine curettage,uterine irradiation, Asherman syndrome, uterine leiomyomata, uterine anomalies, hypertensive disorders of pregnancy and smoking. (1,2) Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion also and rates of maternal death are increased for women with PAS. Additionally, patients with PAS are more likely to require hysterectomy at the time of delivery or during the postpartum period and have longer hospital stays states.(3) According to FIGO Classification of PAS Disorders 2019 There are three grades. Grade 1: abnormally adherent placenta (placenta adherent or accreta) - attached directly to the surface of the middle layer of the uterine wall (myometrium) without invading it, Grade 2: abnormally invasive placenta (increta) - invasion into the myometrium and Grade 3: abnormally invasive placenta (percreta) invasion may reach surrounding pelvic tissues, vessels and organs.(4) Nowadays, fertility sparing and conservative methods can be applied. These methods include placenta left in situ, cervical inversion technique , triple-P procedure, cervico-isthmic compression suture and anterior wall uterine resection
Detailed Description
Study Design & Area:
Randomized controlled trial (RCT) of pregnant women recruited from Department of Obstetrics and Gynecology Mansoura University Hospitals during September 2020 until September 2021 and may be extended if needed.
The study groups will undergo:
Informed consent
History:
Personal: (age, duration of marriage, special habits). Menstrual history Obstetric: (parity, mode of delivery, fetal outcome). Present history of any medical or obstetric problems. Past medical and surgical history. Clinical examination : General and obstetric examination
Calculation of Gestational Age :
Gestational age will be calculated by adding 280 days (40weeks) to the first day of the last menstrual period or by ultrasound.
Investigation:
Lab investigation:- Complete blood count , Bleeding profile, international normalization ratio, liver function tests, kidney function tests
Ultrasound:
Ultrasound Finding:- i. Establish the presence of a living fetus. ii. Estimate the age of the pregnancy. iii. Diagnose congenital abnormalities of the fetus. iv. Evaluate the position of the fetus. v. Determine the amount of amniotic fluid around the baby. vi. Assess fetal growth. vii. Assess fetal well-being. viii. Evaluate the position of the placenta.
- When the antepartum diagnosis of placenta accreta is made, it is usually based on ultrasound findings in the second or third trimester. Sonographic findings that may be suggestive of placenta accreta include:
Loss of normal hypoechoic retroplacental zone.
Multiple vascular lacunae (irregular vascular spaces) within placenta, giving "Swiss cheese" appearance.
Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface.
Retroplacental myometrial thickness of <1 mm. 3 - Color Doppler criteria:
Diffuse or focal lacunar flow pattern.
Sonolucent vascular lakes with turbulent flow typified by high-velocity (peak systolic velocity>15 cm/s) and low-resistance waveform.
Markedly dilated vessels over the peripheral subplacental region (6)
Surgical Procedure:
Preparation of the patient before surgery:
Patient will shave their pubic hair , take a shower with an antiseptic soap, antibiotic prophylaxis and urinary catheter insertion .
Caesarean section steps :
After spinal anesthesia and skin sterilization Abdominal Incision: Pfannenstiel incision then cut the subcutaneous fat and rectus sheath and blunt entry into the peritoneal cavity .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Placenta Accreta
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
- Randomized controlled trial (RCT) of pregnant women recruited from Department of Obstetrics and Gynecology Mansoura University Hospitals for elective termination of pregnancy
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
Circular isthmic-cervical sutures
Arm Title
Group B
Arm Type
Experimental
Arm Description
Resection of the infiltrated part of anterior uterine wall
Intervention Type
Procedure
Intervention Name(s)
Cervico- isthmic compression suture
Intervention Description
Circular isthmic-cervical sutures will be applied . To avoid ureter and bladder injury, the bladder will be reflected downward. A silastic drain will be inserted into internal and through the external os , so as to drain the uterine cavity and to keep the cervical canal open. Firstly, at the left side of the uterus, a Vicryl number two (No..2) stitch will be inserted very close to the cervix from the anterior to the posterior side of the broad ligament.
Intervention Type
Procedure
Intervention Name(s)
Anterior wall uterine resection:
Intervention Description
After fetal delivery, two corners of the uterine incision and the superior and inferior lips will be clamped immediately by four Mayo clamps. Blunt dissection downward to the bladder-uterus peritoneal reflection will perform, to the partial anterior wall of the uterine myometrium where the placenta was deeply adherent (a myometrium defect, with only the serous layer of the uterus) will be respected, together with the placenta. It is important to ensure that sufficient myometrium above the peritoneal reflection will be available for an optimum closure. Then, as much remaining placenta as possible will be removed piecemeal from the edge of the uterine incision. Clamps and multiple hemostatic sutures will be applied rapidly
Primary Outcome Measure Information:
Title
estimated blood loss
Description
The amount of blood drawn into the storage jar during surgery (suction apparatus).
The weight of blood-soaked gauze pads, gauzes, and surgical dressings minus their preoperative weight, and corresponding conversion according to the proportion of 1.05 g in weight to 1 ml in volume.
Time Frame
from the start of uterine incision till closure of uterine wall
Secondary Outcome Measure Information:
Title
hemoglobin deficit
Description
Compare hemoglobin and hematocrit values before and after operation.
Time Frame
from the induction of anesthesia till 2 hours after the end of surgery
Title
complication rate
Description
Injury to local organs (e.g., bowel, bladder, uterus and neurovascular structures in the retroperitoneum and lateral pelvic sidewalls from placental implantation and its removal).
Postpartum hemorrhage, Internal hemorrhage.
Amniotic fluid embolism.
Massive blood transfusion: acidosis, hypothermia, coagulopathy, electrolyte abnormalities and infection.
Postoperative thromboembolism, infection, multisystem organ failure, and maternal death
Hysterectomy.
Time Frame
from the start of induction of anesthesia till 24 hours after the end of surgery
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
pregnant females diagnosed to have placenta Previa or morbidly adherent placenta
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
1- Patient with FIGO classification of PAS disorders Grade 1 & Grade 2 which diagnosed by :
Loss of normal hypoechoic retroplacental zone.
Multiple vascular lacunae (irregular vascular spaces) within placenta, giving "Swiss cheese" appearance.
Retroplacental myometrial thickness of less 1 mm. 2- Patient welling to preserve fertility.
Exclusion Criteria:
1- Patient with FIGO classification of PAS disorders Grade 3 (interruption of the hyperechoic border between the uterine serosa and bladder by US).
2- Age : >40 years old. 3- Patient has medical disorders: cardiac disease, uncontrolled DM, chronic renal disease, chronic liver disease.
4- Patient who refuse to participate in the study.
Facility Information:
Facility Name
Faculty of Medicine
City
Mansoura
State/Province
Dakahlia
ZIP/Postal Code
050
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31173360
Citation
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019 Jul;146(1):20-24. doi: 10.1002/ijgo.12761.
Results Reference
background
PubMed Identifier
32698993
Citation
Jauniaux E, Kingdom JC, Silver RM. A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021 Apr;72:102-116. doi: 10.1016/j.bpobgyn.2020.06.007. Epub 2020 Jun 27.
Results Reference
background
PubMed Identifier
29673673
Citation
Zhao X, Tao Y, Du Y, Zhao L, Liu C, Zhou Y, Wei P. The application of uterine wall local resection and reconstruction to preserve the uterus for the management of morbidly adherent placenta: Case series. Taiwan J Obstet Gynecol. 2018 Apr;57(2):276-282. doi: 10.1016/j.tjog.2018.02.017.
Results Reference
background
Learn more about this trial
Conservative Management of Morbidly Adherent Anterior Situated Placenta
We'll reach out to this number within 24 hrs